MLchartDataset catalogue

personalized synthetic long peptide breast cancer vaccine

Term · Oncology and biomedicine · MLC-T-ONC-015990

A cancer vaccine consisting of one or more long, synthetic peptides derived from patient-specific breast cancer tumor-associated antigens (TAAs), with potential immunomodulating and antineoplastic activities. Upon intramuscular administration of the personalized synthetic long peptide breast cancer vaccine, the peptides stimulate the host immune system to mount a cytotoxic T-lymphocyte (CTL) response against tumor cells expressing the TAAs, which results in tumor cell lysis.

Table 1. Record
IdentifierMLC-T-ONC-015990
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-015990",
  "term": "personalized synthetic long peptide breast cancer vaccine",
  "field": "Oncology and biomedicine",
  "definition": "A cancer vaccine consisting of one or more long, synthetic peptides derived from patient-specific breast cancer tumor-associated antigens (TAAs), with potential immunomodulating and antineoplastic activities. Upon intramuscular administration of the personalized synthetic long peptide breast cancer vaccine, the peptides stimulate the host immune system to mount a cytotoxic T-lymphocyte (CTL) response against tumor cells expressing the TAAs, which results in tumor cell lysis.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/personalized-synthetic-long-peptide-breast-cancer-vaccine/"
}

Record 13,030 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.